Skip to main content
. 2012 Nov 19;30(36):4493–4500. doi: 10.1200/JCO.2012.39.7695

Table 1.

Baseline Demographics and Clinical Characteristics of Final Study Population by Length of Time From Biopsy-Confirmed Diagnosis to Treatment

Demographic or Clinical Characteristic 0 to 59 Days From Biopsy-Confirmed Diagnosis to Treatment (n = 1,603)
≥ 60 Days From Biopsy-Confirmed Diagnosis to Treatment (n = 183)
P*
No. of Patients % No. of Patients %
Demographic
    Age, years .58
        < 45 254 16 27 15
        45-54 280 17 40 22
        55-64 344 21 43 24
        65-74 336 21 39 21
        75-84 314 20 26 14
        ≥ 85 75 5 8 4
    Race .04
        White 906 57 89 49
        Nonwhite 697 44 94 51
    Marital status .99
        Married 264 16 33 18
        Single 225 14 26 14
        Divorced/separated 252 16 28 15
        Widowed 392 24 44 24
        Unknown 470 29 52 28
    Rural/urban status .04
        Metropolitan 891 56 113 62
        Nonmetropolitan 705 44 69 38
    HPSA 1.00
        HPSA 42 3 4 2
        Non-HPSA 1,554 97 178 98
    Year of diagnosis .61
        2000 508 32 64 35
        2001 548 34 62 34
        2002 547 34 57 31
Tumor/cancer characteristics
    Stage at diagnosis .15
        In situ 167 10 29 16
        Localized 783 49 86 47
        Regional 570 36 61 33
        Distant 83 5 7 4
    Tumor size, mm .70
        0-9 208 13 22 12
        10-19 411 26 52 28
        20-49 582 36 60 33
        ≥ 50 166 10 17 9
        Unknown 236 15 32 18
    Hormone receptor status .09
        Positive 836 52 92 50
        Negative 298 19 25 14
        Unknown/undetermined 469 29 66 36
Morbidity indicators
    Charlson comorbidity index .85
        0 726 45 82 45
        1-2 587 37 68 37
        3-5 214 13 22 12
        ≥ 6 76 5 11 6
    Blind or disabled§ .36
        Yes 381 24 38 21
        No 1,222 76 145 79
Location of care
    Assisted living care .70
        Yes 145 9 15 8
        No 1,458 91 168 92
    Home health care .02
        Yes 846 53 80 44
        No 757 47 103 56
Procedures conducted between diagnosis and treatment
    Additional biopsies < .001
        Any 154 10 36 20
        None 1,449 90 147 80
    Medical imaging .27
        Any 83 5 13 7
        None 1,520 95 170 93
    Hospitalization (not cancer related) < .001
        Any 39 2 15 8
        None 1,564 98 168 92
    Emergency department visit (not cancer related) < .001
        Any 23 1 10 6
        None 1,580 99 173 95
Initial treatment information
    Type of treatment first received < .001
        Surgery 1,334 83 117 64
        Radiation 63 4 14 8
        Chemotherapy 149 9 31 17
        Hormonal or biologic 57 4 21 12
Treatment types received
    Surgery .19
        Breast-conserving surgery 579 36 77 42
        Mastectomy 989 62 101 55
        None 35 2 5 3
    Radiation therapy .79
        Any 824 51 96 53
        None 779 49 87 48
    Chemotherapy .05
        Any 683 43 64 35
        None 920 57 119 65
    Hormonal or targeted biologic therapy .38
        Any 458 29 58 32
        None 1,145 71 125 68

NOTE. Percentages may not add to 100% because of rounding error.

Abbreviation: HPSA, health professional shortage area.

*

P value is from χ2 test.

Eight women did not have information about county of residence at diagnosis.

P value is from Fisher's exact test.

§

Only two women were blind.